230 results on '"Lohmann, V"'
Search Results
2. Novel perspectives for Hepatitis A Virus therapy resulting from comparative analysis of Hepatitis C Virus and Hepatitis A Virus RNA replication: O-21
3. Hepatitis C virus replicons: dinosaurs still in business?
4. Verwendung der Infrastruktur der Stationsleittechnik für Online Condition Monitoring für netzkritische Komponenten
5. Biochemical and structural analysis of the NS5B RNA-dependent RNA polymerase of the hepatitis C virus
6. Mutations in HCV NS3 but no Sec14L2 variants alter HCV RNA replication of natural occuring viruses in cell culture
7. Chemical interaction of B4C, B, and C with Mo/Si layered structures.
8. Enhanced diffusion upon amorphous-to-nanocrystalline phase transition in Mo/B4C/Si layered systems.
9. Membrane alterations induced by nonstructural proteins of human norovirus
10. SAT-347 - Mutations in HCV NS3 but no Sec14L2 variants alter HCV RNA replication of natural occuring viruses in cell culture
11. Mechanisms of osteopontin-mediated effects on chronic hepatic inflammation and cancer
12. Monocytes Affect Natural Killer cell Antiviral IFN-γ Production in HCV Infection via Inflammasome-mediated IL-18 Secretion
13. First case description of a quadruple therapy with silibinin, telaprevir, ribavirin and pegIFNα2a in a liver transplanted patient with chronic Hepatitis C Virus infection
14. Inhibition of WNT signalling interferes with HCV replication
15. Down regulation of osteopontin interferes with HCV replication by inhibition of WNT signalling in vitro
16. 847 COFFEE INTERFERES WITH HCV REPLICATION IN VITRO BY INHIBITION OF WNT SIGNALING
17. 785 INNATE SIGNALING BY HEPATITIS C VIRUS IS RIG-I AND MDA5 DEPENDENT AND MODULATED BY NS5A DOMAIN II
18. 1176 ANALYSIS OF HCV RESISTANCE TO SILIBININ IN VIVO AND IN VITRO
19. 454 PRODUCTION AND CHARACTERIZATION OF HEPATOTROPIC HEPATITIS B VIRUS (HBV) PRES1-INTERFERON a (IFNa) FUSIONS FOR TARGETED ANTIVIRAL THERAPIES
20. 792 HBV-HCV COINFECTION: A NOVEL MODEL SYSTEM REVEALS INSIGHTS INTO IMMUNOLOGICAL MECHANISMS OF VIRAL INTERFERENCE
21. 129 MODULATION OF PHOSPHORYLATION OF HEPATITIS C VIRUS NONSTRUCTURAL PROTEIN 5A BY THE LIPID KINASE PI4KIIIα
22. 45 RAPID AND EFFICIENT ANTIGEN PROCESSING AND PRESENTATION OF A PROTECTIVE AND IMMUNODOMINANT HLA-B*27-RESTRICTED HEPATITIS C VIRUS-SPECIFIC CD8+ T CELL EPITOPE
23. Induction of heme oxygenase 1 by HMG-CoA-Reductase inhibitors interferes with HCV replication
24. 45 IDENTIFICATION OF EFFECTORS OF THE INTERFERON-INDUCED ANTIVIRAL RESPONSE AGAINST HEPATITIS C VIRUS
25. 90 IMMUNODOMINANCE OF HLA-A*0201 RESTRICTED HEPATITIS C VIRUS-SPECIFIC CD8+ T CELL RESPONSES IS DETERMINED BY THE NAIVE PRECURSOR FREQUENCY
26. 41 RECRUITMENT AND ACTIVATION OF A LIPID KINASE BY NS5A OF THE HEPATITIS C VIRUS IS ESSENTIAL FOR THE INTEGRITY OF THE MEMBRANOUS REPLICATION COMPARTMENT
27. Annexin A2 as a differential diagnostic marker of hepatocellular tumors
28. Enzymatic activity of Phosphatidyl-inositol-4 kinase III alpha (PI4KIIIα) is critically involved in HCV replication and regulated by HCV NS5A
29. Ex vivo analysis of HCV-specific CD8+ T cell antiviral efficacy using a novel immunological model
30. Experimental models to study the immunobiology of hepatitis C virus
31. Chemical interaction of B4C, B, and C with Mo/Si layered structures
32. Enhanced diffusion upon amorphous-to-nanocrystalline phase transition in Mo/B4C/Si layered systems
33. Analysis of HCV-specific CD8+ T-cell cytolytic effector functions and their contribution to antiviral efficacy using a novel immunological model
34. The Heme oxygenase 1 product Biliverdin interferes with HCV replication by increasing anti-viral interferon response
35. Crystal structure of the NS5B polymerase from Hepatitis C Virus (HCV) strain JFH1
36. Diffusion and interaction studied nondestructively and in real-time with depth-resolved low energy ion spectroscopy
37. Analysis of CD8+ T cell-mediated inhibition of hepatitis C virus replication using a novel immunological model
38. [430] RIBAVIRIN ACTS AS HEPATITIS C VIRUS MUTAGEN ON NONSTRUCTURAL 5B QUASISPECIES IN VITRO AND DURING ANTIVIRAL THERAPY
39. Ribavirin als RNA-Virusmutagen: Analyse der NS5B Quasispezies-Komplexität in HCV-Replikonzellen und bei Patienten mit chronischer Hepatitis C
40. 417 Subgenomic hepatitis C replicon deriving from a clinical isolate with virologic non-response to IFN-based therapy and IFN resistance in vitro
41. A target on the move: Innate and adaptive immune escape strategies of hepatitis C virus
42. Mechanismen der Fibroseprogression bei chronischer Hepatitis C
43. New strategies for substation control, protection and access to information
44. Biochemical properties of hepatitis C virus NS5B RNA-dependent RNA polymerase and identification of amino acid sequence motifs essential for enzymatic activity
45. Complex formation between the NS3 serine-type proteinase of the hepatitis C virus and NS4A and its importance for polyprotein maturation
46. The Replicon System as an Efficient Tool to Study HCV RNA Replication.
47. Novel cell culture systems for the hepatitis C virus
48. Selective stimulation of hepatitis C virus and pestivirus NS5B RNA polymerase activity by GTP.
49. Hepatitis C virus full-length genomes with cell culture adaptive mutations in NS3 and NS5A (replicon-derived) replicate efficiently in HUH-7 cells but are highly attenuated in vivo
50. Less impact of power failures due to substation automation
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.